Here are five highlights:
1. Mr. Thomas is the founder and CEO of Roka Bioscience, which develops molecular assays for biopharmaceutical processing and food safety among other industrial testing applications.
2. A director of AbioMed, Mr. Thomas also serves as a director of Aegerion Pharmaceuticals and RTI Surgical.
3. He used to serve as chairman, CEO and president of regenerative medicine company, LifeCell (acquired by KCI).
4. He also held several senior positions at inhalation anesthetics and acute care pharmaceutical company, Ohmeda, at which he worked for 15 years.
5. Mr. Thomas earned his master of business administration degree from Columbia University Graduate School of Business in New York City.
More articles on devices:
Globus Medical to acquire Alphatec Holdings’ international business for $80M — 9 key insights
DeGen Medical’s F1 MPS Modular Pedicle Screw System for JOUST MIS procedure receives FDA approval: 4 things to know
NuVasive revenue up 16.4% to $236.2M in Q2 of 2016: 9 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
